On March 3, 2023, CytoDyn Inc. closed the transaction. The company has now received binding subscription agreements to purchase 21.3 million units at a total purchase price of $0.23 per unit for the gross proceeds of $4,899,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 USD | +1.27% | -6.67% | -28.21% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-28.21% | 139M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.23% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. announced that it has received $4.899 million in funding